double-blind

(redirected from double-blinded)
Also found in: Dictionary.

double-blind

, double-blinded (dub'el-blind')
Pert. to a method, study, or clinical trial in which neither the subjects nor the investigators know the identities of the subjects nor what treatment or medication, if any, the subjects receive. A double-blind study attempts to eliminate observer and subject bias.
See: blind (2); single-blind
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
After the double-blinded period, all patients entered 24 weeks of open-label treatment with eltrombopag (Lancet.
This kind of study is double-blinded, meaning that neither the participants nor the researchers know who is receiving the new treatment until the study is completed.
The multi-part study includes single and multiple dose parts, and a placebo-controlled, randomized double-blinded cross-over study comparing M254 to IVIg.
The ORIENT is a double-blinded study to examine the effectiveness of olmesartan medoxomil on patients with mild to moderate diabetic nephropathy.
Unlike most oral dosage forms, this product required a 325 patient, 18 center, double-blinded, three-way, placebo controlled clinical study to demonstrate bio-equivalence.
As announced in November, Aclaris completed enrollment of AA-201 Topical, a randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the safety, efficacy and dose response of two concentrations of ATI-502 for the treatment of AA.
placebo, with a one-week run-in period, followed by an eight-week double-blinded treatment period.
AnaptysBio expects to report top-line efficacy and safety data, including improvement in Forced Expiratory Volume in One Second, from its ongoing double-blinded, placebo-controlled severe eosinophilic asthma trial Phase 2a trial, where approximately 24 adult severe eosinophilic asthma patients are treated with a 300mg intravenous single dose of etokimab versus placebo, each in combination with inhaled corticosteroids and long-acting beta agonists as background therapy, in Q3.